NF-κB is a crucial transcriptional factor that adjusts inflammatory reactions by regulating the transcription of diversified cell genes and has been authenticated as a therapeutical target for the remedy of enteric inflammation and IBD (Amirshahrokhi and Imani, 2023; Tsopmejio et al., 2022). Here, NFKB1 is linked to inflammatory bowel disease.